Investorideas.com

 


BiodefenseStocks.com - A Leading Global Website for Biodefense Stocks

BioDefenseStocks.com - investing ideas in biodefense stocks

Like Biodefense Stocks? View our Biodefense Stocks Directory


Featured biotech stocks

Aethlon Medical, Inc.

(NasdaqCM:AEMD)


Aethlon Medical (NasdaqCM:AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

Featured biotech properties

Defense and Security News

#Cybersecurity Sector Snapshot: Cyberfort Software (OTC: $CYBF), CyberArk, ( $CYBR), ETFMG Prime Cyber Security ETF ( $HACK), FireEye ( $FEYE)
Point Roberts, WA - November 16, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering defense and cybersecurity stocks releases a sector snapshot, following the money in both spending and costs, looking at recent news and developments in the sector.

Follow the Money in #Cybersecurity; Cyberfort Software (OTC: $CYBF), CyberArk, ( $CYBR), ETFMG Prime Cyber Security ETF ( $HACK), FireEye ( $FEYE)
Point Roberts, WA - November 15, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering defense and cybersecurity stocks releases a sector snapshot, following the money in both spending and costs, looking at recent news and developments in the sector.

CEO of DirectView Holdings (OTC: $DIRV) Discusses Contracts and Future of Security Surveillance Sector Using #AI; companies mentioned: GRUMA (GRUMAAB.MX), FLIR Systems (NASDAQ: $FLIR), Apple ( $AAPL)
Point Roberts, WA - October 30, 2018 (Investorideas.com Newswire) Investorideas.com and Homelanddefensestocks.com, covering security and defense stocks release an exclusive podcast interview with Roger Ralston, the CEO of DirectView Holdings, Inc. (OTC: DIRV).

Notilo Plus launches #iBubble, the world's first intelligent autonomous and fully wireless underwater #drone
Marseille, France - October 29, 2018 (Investorideas.com Newswire) Notilo Plus, a company developing intelligent, autonomous underwater systems, today announces the global commercial launch of iBubble, the world's first fully wireless, autonomous and intelligent underwater drone.

Developer of Weapons Detection Systems Partners with Cisco Systems
October 29, 2018 (Investorideas.com Newswire) The collaboration should help advance the company's mission to help security personnel "deter, detect and defend."

#Security Podcast: CEO of DirectView Holdings (OTC: $DIRV) Discusses Contracts with Rogers-O'Brien Construction, GRUMA Subsidiary, Mission Foods and the next Evolution of Security Surveillance Technology; #AI
Point Roberts, WA - October 29, 2018 (Investorideas.com Newswire) Investorideas.com and Homelanddefensestocks.com, covering security and defense stocks release an exclusive podcast interview with Roger Ralston, the CEO of DirectView Holdings, Inc. (OTC: DIRV).

#Threat Detection News: Patriot One (TSX.V: $PAT.V) (OTCQX: $PTOTF) @patriot1tech Invited to Partner with Cisco (NASDAQ: $CSCO) on Innovation Program
TORONTO, CANADA - October 25, 2018 (Investorideas.com Newswire) Threat detection news- Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company"), developer of the revolutionary PATSCAN concealed weapons detection system, has been invited to partner with Cisco Systems (NASDAQ: CSCO) on its global innovation program. The partnership aims to assist effective commercial deployment of the PATSCAN family of threat detection solutions.

#Security Stock News: Patriot One (TSX.V: $PAT.V) (OTCQX: $PTOTF) @patriot1tech Partners with Cisco Systems (NASDAQ: $CSCO) on Innovation Program
TORONTO, CANADA - October 24, 2018 (Investorideas.com Newswire) Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company"), developer of the revolutionary PATSCAN concealed weapons detection system, has been invited to partner with Cisco Systems (NASDAQ: CSCO) on its global innovation program.

Investor Ideas Adds New Stocks this week; (NYSE: $NIO), (NYSE: $LTHM), (NYSE: $D), (ASX: FLC.AX), (CSE: $SDZ.C)
Point Roberts, WA and Delta, BC - October 20, 2018 (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week's additions to its global stock directories in cleantech, water, defense, luxury brands and agriculture.

Goode Intelligence forecasts that almost 579 million #biometric payment cards will be in use around the world by 2023 to enable frictionless customer authentication for higher-value contactless card transactions
London, United Kingdom - October 18, 2018 (Investorideas.com Newswire) Goode Intelligence's (www.goodeintelligence.com) latest research, Biometrics for Payments; Market and Technology Analysis, Adoption Strategies and Forecasts 2018-2023 - Second Edition, reveals that biometrics has become an important tool in the fight against fraud in almost all of the channels that payment is supported.

Subscribe to Defense and Security News RSS

Submit Articles   Search More Articles

Defense stocks Indices and ETF's

  • PHLX DEFENSE SECTOR INDEX (Philadelphia: ^DFX)
  • S&P Sector Indices Brochure
  • Standard and Poor's 500 Aerospace & Defense Index is a capitalization-weighted index. The index was developed with a base level of 10 for the 1941-43 base period. This is a GICS level 4 sub-industry group. The parent index is SPX. This is a GICS Level 4 Sub-Industry group.
  • The Amex Defense Index (DFI) is an equal dollar weighted Index designed to represent a cross section of widely held, highly capitalized companies involved in providing systems, equipment and services to the United States government and its allies for the purpose of supporting military, defense and intelligence efforts. The component stocks operate in industry segments that include, but are not limited to, military aircraft manufacturing, shipbuilding, ground transportation, aerospace instrumentation and technology, specialized communication and radar systems, ammunition and weapon systems.
  • The iShares Dow Jones U.S. Aerospace & Defense Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Select Aerospace & Defense Index.
  • The SPADE Defense Index (AMEX: DXS) is a modified market cap-weighted index that was developed to provide a financial benchmark for the performance of companies involved with the defense, homeland security, and space. More than 50 companies currently comprise the index. Information on the Index -- including its methodology, rules, constituents, and performance -- can be found at http://www.spadeindex.com. In October 2005, the first (and currently only) exchange traded fund on defense and homeland security was launched by Powershares. The Powershares Aerospace & Defense Portfolio ETF trades under the symbol 'PPA' and is designed to track the performance of the SPADE. - more info

Biodefense Stocks Directory Preview

Aeolus Pharmaceuticals, Inc ( OTC:AOLS ) is developing a platform of a new class of broad-spectrum, catalytic-antioxidant compounds that protect healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Department of Health and Human Services, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing, and preclinical and clinical studies made by US Government agencies in AEOL 10150, including the contract with BARDA valued, with options, at up to $118.4 million, to efficiently develop the compound for use in oncology.

Aethlon Medical (NasdaqCM:AEMD) is a leading developer of immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® eliminates life-threatening disease targets that are often shielded from the immune system and not well addressed by traditional drug therapies. The technology captures circulating viruses, bacterial toxins and cancer promoting exosomes through affinity attachment to a unique structure that cloaks these targets from immune detection. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Aethlon is also the majority owner of Exosome Sciences, Inc., a company focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

Alexium International Group ( ASX:AJX.AX ) is engaged in developing and licensing its intellectual property, Reactive Surface Treatment (RST) technology. Alexium is focused on developing the RST technology for a range of military and commercial applications. Alexium's Reactive Surface Treatment (RST) is a technology for nanoscopic coatings that combines advanced materials chemistry with a processing step. Alexium's Reactive Surface Treatment (RST) uses cold microwave energy to direct a precursor's polymerization onto a substrate's surface. Its technology is used in textiles, air/fluid filtration, industrial coatings, composite fibers, leather, glass/lens surface treatment, bulk chemicals and thin films. BIODEFENSE: Responding to specific military and first responder needs, Alexium developed the Cleanshell® chemistry to offer a new generation of liquid repellency protection in chemical and biological threat scenarios. Cleanshell® CB is an advanced repellency treatment, optimized for chemical and biological protection. Cleanshell® CB has been optimized to provide excellent water and oil repellency, but has also dramatically increased the repellency of Chemical Warfare Agent (CWA) simulants. Cleanshell® CB offers days of protection versus minutes for conventional fluorocarbon repellency finishes.

American Science and Engineering, Inc ( NasdaqGS: ASEI ) is a leading worldwide supplier of innovative X-ray inspection systems. With over 50 years of experience in developing advanced X-ray security systems, the Company's product line utilizes a combination of technologies, including patented Z Backscatter™ technology, Radioactive Threat Detection (RTD), high energy transmission and dual energy transmission X-ray. These technologies offer superior X-ray threat detection for plastic explosives, plastic weapons, liquid explosives, dirty bombs and nuclear devices. AS&E's complete range of products include cargo inspection systems for port and border security baggage screening systems for facility and aviation security, and personnel and passenger screening systems. AS&E® systems protect high-threat facilities and help combat terrorism, trade fraud, drug smuggling, weapon smuggling, illegal immigration, and people smuggling.

BRUKER Corporation ( NasdaqGS: BRKR ) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial, diagnostics and applied analysis. CBRN (Chemical, biological, radiological, and nuclear defense) : The CBRNE threats facing Armed Forces, Emergency and Security Services across the globe are complex. Simple and reliable solutions are required in order to provide protection and fast, effective response. As the market leader in CBRNE for over 20 years, Bruker understand the threat and needs of those operating against it. Our trusted equipment and software is installed around the world providing unrivalled protection. Our equipment is always easy to use and enables full spectrum Detection, Identification and Monitoring utilising state of the art technology.

Cepheid ( NasdaqGS: CPHD ) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the Company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the Company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. BIOTHREATS : The Cepheid GeneXpert® System makes biothreat agent detection possible in minutes — all from unprepared samples. This easy-to-use, automated and highly accurate real-time PCR instrument combines the ingenuity of more than 30 patents into a sophisticated genetic tool for first responders. A patented, disposable, cartridge test for anthrax is available now, and can be performed on-site — delivering critical answers in critical situations.

Cleveland BioLabs, Inc. ( NasdaqCM:CBLI ) is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant medical need. The company's lead product candidates are Entolimod, which is being developed as radiation countermeasure and a potential cancer treatment and Curaxin CBL0137, our lead oncology product candidate. BIODEFENSE:Entolimod (CBLB502) Biodefense

Dynasil Corporation of America ( NasdaqGM:DYSL ) develops and manufactures detection and analysis technology, precision instruments and optical components for the homeland security, medical and industrial markets. Combining world-class technology with expertise in research and materials science, Dynasil is commercializing products including dual-mode radiation detection solutions for Homeland Security and commercial applications, probes for medical imaging and sensors for non-destructive testing.

Electronic Sensor Technology ( OTC:ESNR) develops, manufactures, and sells electronic devices used for vapor analysis. The company offers zNose, an electronic nose designed for various industry applications, which can detect odors and chemical vapors produced by explosives, chemicals, and biological weapons, as well as used for identifying hazardous industrial materials, improvised explosives, and flammable materials. Its product is used in the homeland security, chemical and petrochemical, environmental, life science, and food and beverage industries. The company also provides spare parts, such as columns, saw detectors, and traps; and accessories, including rugged shipping case, battery assemblies, battery chargers, DC/AC inverters, desorbers, heaters, remote samplers, sample injectors, system controllers, user tool kits, and water traps, as well as support and validation services. Electronic Sensor Technology offers its products through online store.

Emergent BioSolutions, Inc. ( NYSE:EBS ) is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company provides the world's only FDA-licensed anthrax vaccine to protect against anthrax disease, BioThrax®.

See the full stock directory here